Quarterly ResultApr 26, 2026, 05:30 AM
AGMB Reports FY2025 Results, Confirms 2026 Outlook; AGM Set for May 26
AI Summary
Agomab Therapeutics NV announced its full year 2025 financial results and reaffirmed its 2026 outlook via a press release on April 23, 2026. Concurrently, the company published materials for its Annual General Meeting (AGM), scheduled for May 26, 2026, at 4:00 pm CEST. These AGM materials, including the convening notice and annual report, are incorporated by reference into the company's Form S-8 registration statement.
Key Highlights
- Agomab Therapeutics NV reported its full year 2025 financial results.
- The company confirmed its 2026 outlook.
- An Annual General Meeting (AGM) is scheduled for May 26, 2026, at 4:00 pm CEST.
- AGM materials, including the convening notice and annual report, were published on the company's website.
- AGM materials are incorporated by reference into the company's Registration Statement on Form S-8 (File No. 333-294220).
Price Impact
More from AGMB